MAIA Biotechnology

About:

MAIA Biotechnology is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.

Website: https://maiabiotech.com/

Twitter/X: maiabiotech

Top Investors: KIZOO Technology Capital, Checkmate Capital, Stan V. Smith, MDL Investments, Benjamin Kong

Description:

MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.